What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to announce that CME Group Inc. and GFI Group Inc. have received all necessary material regulatory approvals to proceed with the acquisition of GFI Group by CME Group. It also informs investors about the upcoming GFI stockholder meeting to vote on the transaction.

When can investors expect the acquisition to be completed?

While the filing indicates that material regulatory approvals have been received and the GFI stockholder meeting is scheduled for January 27, 2015, it does not provide a specific closing date. The completion of the transaction is subject to the satisfaction of other conditions outlined in the definitive agreements and the approval of GFI stockholders.

Where can investors find more detailed information about the GFI acquisition?

Investors can find more detailed information in the definitive proxy statement/prospectus filed by GFI on Form S-4 (declared effective December 24, 2014) and other relevant SEC filings by both CME Group and GFI. These documents are available on the SEC's website and can be obtained directly from the companies' investor relations departments.

What are the potential risks associated with this acquisition mentioned in the filing?

The filing highlights several risks and uncertainties, including the possibility of termination of the definitive agreements, failure to obtain required stockholder approval, and the inability to satisfy other closing conditions. It also mentions risks related to business disruption, potential customer and employee loss, legal proceedings, competition, and changes in laws and regulations.

CME 8-K SEC Disclosure

Summary

CME Group Inc. (CME) filed an 8-K report on January 5, 2015, announcing significant progress in its previously disclosed acquisition of GFI Group Inc. The key update is the receipt of all material regulatory approvals required to close the transaction. Additionally, GFI Group Inc. scheduled its special meeting of stockholders for January 27, 2015, where the acquisition will be presented for approval. This filing indicates that the transaction is moving closer to completion, which is a material development for CME Group's investors. The report also emphasizes the importance of the definitive proxy statement/prospectus filed on Form S-4, which was declared effective by the SEC on December 24, 2014, and subsequently mailed to GFI stockholders. This document contains crucial information for GFI investors regarding the proposed merger. CME Group investors are also encouraged to review the filings for details on potential participants in the solicitation and forward-looking statements, which outline various risks and uncertainties associated with the acquisition.

Key Highlights

1CME Group and GFI Group have received all material regulatory approvals necessary to close the acquisition.
2GFI Group will hold a special meeting of stockholders on January 27, 2015, to vote on the acquisition.
3The joint press release announcing these updates was issued on January 5, 2015.
4A Form S-4 registration statement, containing a definitive proxy statement/prospectus, was declared effective by the SEC on December 24, 2014.
5GFI stockholders have commenced receiving the definitive proxy statement/prospectus.
6The filing includes a cautionary statement regarding forward-looking statements and associated risks and uncertainties.
7Exhibit 99.1 contains the joint press release dated January 5, 2015.

CME GROUP INC. 8-K Report, Corporate Update (Jan 6, 2015)

Summary

Key Highlights

Frequently Asked Questions